In this study we investigated if APP-CTFs are detectable in CSF, characterized the major APP-CTF immunoreactive band, and determined whether the levels of this peptide fragment are altered in autosomal dominant AD (ADAD), Down syndrome subjects with Alzheimer’s type dementia (dDS), and sporadic AD subjects (sAD). The gene discussed is APP; the disease is Down syndrome.